VRRM enters its May 19 earnings release carrying the weight of a sharp, broad-based selloff — down 13% over the past month and 8% in the last week alone, closing at $13.10.
The most notable pre-earnings development is the acceleration in short interest. Bears have added meaningfully in recent days: short interest climbed nearly 18% over the past week to 2.6% of the free float. That level remains modest in absolute terms, but the speed of the move — from roughly 3.5 million shares short to over 4.1 million in a matter of days — signals fresh conviction among sellers heading into the print. The borrow market does little to discourage them. Cost to borrow is negligible at 0.43%, and availability remains loose, making it easy and cheap to establish or maintain a short position ahead of results.
Options positioning adds to the cautious tone. The put/call ratio has jumped to 1.16, the highest reading of the past year and meaningfully above its 20-day average of 0.97. That gap reflects a meaningful tilt toward downside protection — traders are paying more for puts than at any point in the last twelve months. The combination of rising short interest and elevated put demand paints a picture of investors bracing for disappointment rather than betting on a positive surprise.
The analyst community has been steadily revising lower. JP Morgan — the only major firm with a recent public move — trimmed its target to $17 just yesterday, the fourth consecutive cut since initiating at $25 in January. Morgan Stanley moved in the same direction in February, lowering to $20. The mean consensus target now sits at $21.43, implying roughly 64% upside from the current price, but that gap reflects how far the stock has fallen rather than fresh analyst optimism. Neither firm has upgraded its rating. EPS momentum scores are middling — ranking around the 62nd–64th percentile — while the 12-month forward EPS growth rank is weak at just the 10th percentile, suggesting the Street sees limited near-term earnings acceleration.
The earnings report will test whether the operational performance justifies any recovery narrative, or whether the widening analyst-to-price gap continues to close from above.
See the live data behind this article on ORTEX.
Open VRRM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
